Home/ Supplements/ Lysine/ L-Lysine 500 mg

L-Lysine 500 mg

product on market Tablet or Pill Viva Vitamins Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for L-Lysine 500 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
250
Servings
Amino acid/Protein
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

500 mg
Market median: 500.0mg (159 products)

Other Ingredients

Cellulose Vegetable Stearin Cellulose Gum Magnesium Stearate Silica
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: As a dietary supplement, take one (1) tablet, two (2) times daily. For extra skin support during stressful times, take two (2) tablets, three (3) times daily, or as directed by a health care professional.

Warnings & Precautions

KEEP OUT OF THE REACH OF CHILDREN.

DO NOT USE IF SAFETY SEAL UNDER CAP IS BROKEN OR MISSING.

Formulation Notes

Contains No: Gluten, sugar, salt, yeast, corn, wheat, lactose, citrus, milk, egg, fish products, artificial coloring, flavoring, or preservatives.

Additional Information

Store in a cool, dry place. Do not refrigerate. Please recycle.

500 MG

FITNESS

GMP Compliant Manufacturing

Lysine is required for collagen synthesis (which benefits the skin). It also plays a role in immune function, and may be important to bone health.†

MADE IN THE USA

Our L-Lysine is a pure crystalline, free form amino acid.

Supports Immune Function & Collagen Synthesis/Skin Health†

Metadata

Product Details

UPC / SKU8 12720 01568 0
DSLD Entry Date2011-11-25
Product TypeAmino acid/Protein
FormTablet or Pill
DSLD ID1758
Data Updated2026-04-11
Research

Research Evidence

3
Research Sources
74
Avg Quality
3
Meta Analysis
A Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2026 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
View all evidence for Lysine →
Compare

Similar Products

View all Lysine products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.